Flowers Lee 4
4 · HCW Biologics Inc. · Filed Dec 3, 2021
Insider Transaction Report
Form 4
Flowers Lee
SVP of Business Development
Transactions
- Exercise/Conversion
Stock Option (Right to Buy)
2021-12-01−4,285→ 12,857 totalExercise: $0.14Exp: 2029-12-18→ Common Stock (4,285 underlying) - Exercise/Conversion
Common Stock
2021-12-01$0.14/sh+4,285$600→ 95,952 total
Footnotes (1)
- [F1]20% of the total shares subject to the stock option grant vested on September 16, 2020; 20% of the total shares subject to the stock option grant vested on September 16, 2021; 25% of the total shares subject to the stock option grant will vest on September 16, 2022; and 35% of the total shares subject to the stock option grant will vest on September 16, 2023.